Intraoperative Methadone Cuts Post-Op Opioid Use in Spine Sx

Share this content:
Intraoperative Methadone Cuts Post-Op Opioid Use in Spine Sx
Intraoperative Methadone Cuts Post-Op Opioid Use in Spine Sx

MONDAY, May 1, 2017 (HealthDay News) -- For patients undergoing posterior spinal fusion surgery, intraoperative methadone administration is associated with reduced postoperative opioid requirements, according to a study published in the May issue of Anesthesiology.

Glenn S. Murphy, M.D., from the University of Chicago Pritzker School of Medicine in Evanston, Illinois, and colleagues conducted a parallel-group randomized trial to examine the effect of methadone on postoperative analgesic requirements, pain scores, and patient satisfaction after complex spine surgery. One hundred twenty patients undergoing posterior spinal fusion surgery were randomly allocated to receive methadone 0.2 mg/kg at the start of surgery or hydromorphone 2 mg at surgical closure.

Data were analyzed for 115 patients. The researchers found that median hydromorphone use was reduced in the methadone group on postoperative days one (4.56 versus 9.9 mg), two (0.6 versus 3.15 mg), and three (0 versus 0.4 mg). At 21 of 27 assessments, the methadone group had lower pain scores at rest, with movement, and with coughing. The methadone group had higher overall satisfaction with pain management until the morning of postoperative day three compared with the hydromorphone group.

"Intraoperative methadone administration reduced postoperative opioid requirements, decreased pain scores, and improved patient satisfaction with pain management," the authors write.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »